Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription

Articles published in Ann Hematol

Retrieve available abstracts of 91 articles:
HTML format
Text format

Single Articles

    December 2018
  1. HOSOKAWA K, Sugimori C, Ishiyama K, Takamatsu H, et al
    Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure.
    Ann Hematol. 2018;97:2289-2297.
    PubMed     Text format     Abstract available

    November 2018
  2. AKRAM Z, Ahmed P, Kajigaya S, Satti TM, et al
    Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan.
    Ann Hematol. 2018 Nov 13. pii: 10.1007/s00277-018-3542.
    PubMed     Text format     Abstract available

  3. LONG Z, Yu F, Du Y, Li H, et al
    Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus.
    Ann Hematol. 2018;97:2047-2054.
    PubMed     Text format     Abstract available

  4. SHALLIS RM, Xu ML, Curtis SA, Medoff E, et al
    Conviction in the face of affliction: a case series of Jehovah's Witnesses with myeloid malignancies.
    Ann Hematol. 2018;97:2245-2248.
    PubMed     Text format    

  5. OLIVEIRA CC, Rocha JTQ, Silva GF, Biglia B, et al
    Would you think of histiocytic sarcoma in this fine-needle aspiration?
    Ann Hematol. 2018;97:2257-2259.
    PubMed     Text format    

    October 2018
  6. YABE M, Koike T, Ohtsubo K, Imai E, et al
    Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
    Ann Hematol. 2018 Oct 27. pii: 10.1007/s00277-018-3517.
    PubMed     Text format     Abstract available

  7. WANG Z-, Yu H-, Cao F-, Liu Z-, et al
    Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.
    Ann Hematol. 2018 Oct 19. pii: 10.1007/s00277-018-3523.
    PubMed     Text format     Abstract available

  8. MAKISHIMA K, Obara N, Ishitsuka K, Sukegawa S, et al
    High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease.
    Ann Hematol. 2018 Oct 15. pii: 10.1007/s00277-018-3521.
    PubMed     Text format    

  9. REN Q, Zhou YL, Wang L, Chen YS, et al
    Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia.
    Ann Hematol. 2018;97:1933-1939.
    PubMed     Text format     Abstract available

  10. HAGHPANAH S, Zarei T, Eshghi P, Zekavat O, et al
    Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia.
    Ann Hematol. 2018;97:1919-1924.
    PubMed     Text format     Abstract available

  11. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
    Ann Hematol. 2018;97:1925-1932.
    PubMed     Text format     Abstract available

  12. FUJITA Y, Nakazato T, Ito C, Masuda K, et al
    A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
    Ann Hematol. 2018;97:2009-2010.
    PubMed     Text format    

    September 2018
  13. LI SS, Hsu YT, Chang C, Lee SC, et al
    Incidence and treatment outcome of aplastic anemia in Taiwan-real-world data from single-institute experience and a nationwide population-based database.
    Ann Hematol. 2018 Sep 3. pii: 10.1007/s00277-018-3486.
    PubMed     Text format     Abstract available

  14. SHAH S, Jain P, Shah K, Patel K, et al
    Immunosuppressive therapy for aplastic anemia: a single-center experience from western India.
    Ann Hematol. 2018 Sep 1. pii: 10.1007/s00277-018-3487.
    PubMed     Text format     Abstract available

  15. CARPIO A, Merino A, Rodriguez-Tajes S, Reverter E, et al
    Massive hemolysis complicating acute granulomatous hepatitis.
    Ann Hematol. 2018;97:1741-1742.
    PubMed     Text format    

    August 2018
  16. FUREDER W, Sperr WR, Gleixner K, Thalhammer R, et al
    Major response of PNH to an AML chemotherapy protocol.
    Ann Hematol. 2018;97:1487-1488.
    PubMed     Text format    

  17. YASUNAGA M, Taoka K, Nakagawa H, Yamada A, et al
    Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review.
    Ann Hematol. 2018;97:1513-1515.
    PubMed     Text format    

    July 2018
  18. YAMAMOTO A, Meguri Y, Fukuda A, Kambara Y, et al
    A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia.
    Ann Hematol. 2018 Jul 10. pii: 10.1007/s00277-018-3430.
    PubMed     Text format    

  19. RINELLI M, Bellacchio E, Berardinelli F, Pascolini G, et al
    Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres.
    Ann Hematol. 2018 Jul 6. pii: 10.1007/s00277-018-3415.
    PubMed     Text format    

  20. CLE DV, Atta EH, Dias DSP, Lima CBL, et al
    Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Ann Hematol. 2018 Jul 5. pii: 10.1007/s00277-018-3416.
    PubMed     Text format     Abstract available

    June 2018
  21. MYINT ZW, Oo TH, Thein KZ, Tun AM, et al
    Copper deficiency anemia: review article.
    Ann Hematol. 2018 Jun 29. pii: 10.1007/s00277-018-3407.
    PubMed     Text format     Abstract available

  22. ARANDA N, Bedmar C, Arija V, Jardi C, et al
    Serum hepcidin levels, iron status, and HFE gene alterations during the first year of life in healthy Spanish infants.
    Ann Hematol. 2018;97:1071-1080.
    PubMed     Text format     Abstract available

    May 2018
  23. BOHME T, Medinger M, Suenderhauf C, Speer O, et al
    Severe anemia after trans-catheter arterial chemoembolization-an unusual presentation of hemoglobin Zurich.
    Ann Hematol. 2018 May 8. pii: 10.1007/s00277-018-3353.
    PubMed     Text format    

  24. CHATTERJEE T, Chakravarty A, Chakravarty S
    Hydroxyurea responses in clinically varied beta, HbE-beta thalassaemia and sickle cell anaemia patients of Eastern India.
    Ann Hematol. 2018;97:893-898.
    PubMed     Text format     Abstract available

  25. NEMTSAS P, Arnaoutoglou M, Perifanis V, Koutsouraki E, et al
    Polyneuropathy and myopathy in beta-thalassemia major patients.
    Ann Hematol. 2018;97:899-904.
    PubMed     Text format     Abstract available

  26. RAGHUNATHAN VM, Whitesell PL, Lim SH
    Sleep-disordered breathing in patients with sickle cell disease.
    Ann Hematol. 2018;97:755-762.
    PubMed     Text format     Abstract available

    April 2018
  27. MICHALAK SS, Rupa-Matysek J, Gil L
    Comorbidities, repeated hospitalizations, and age >/= 80 years as indicators of anemia development in the older population.
    Ann Hematol. 2018 Apr 9. pii: 10.1007/s00277-018-3321.
    PubMed     Text format     Abstract available

  28. MIRLOHI MS, Yaghooti H, Shirali S, Aminasnafi A, et al
    Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with beta-thalassemia major.
    Ann Hematol. 2018;97:679-684.
    PubMed     Text format     Abstract available

    March 2018
  29. RODGERS GM, Gilreath JA
    Eltrombopag as initial monotherapy for severe aplastic anemia-a case report.
    Ann Hematol. 2018 Mar 20. pii: 10.1007/s00277-018-3303.
    PubMed     Text format    

    February 2018
  30. SUZUKI Y, Koya J, Ebisawa K, Abe H, et al
    Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia.
    Ann Hematol. 2018 Feb 7. pii: 10.1007/s00277-018-3248.
    PubMed     Text format    

  31. GHAVAMZADEH A, Sotoudeh M, Hashemi Taheri AP, Alimoghaddam K, et al
    Liver fibrosis alleviation after co-transplantation of hematopoietic stem cells with mesenchymal stem cells in patients with thalassemia major.
    Ann Hematol. 2018;97:327-334.
    PubMed     Text format     Abstract available

    January 2018
  32. ZHAO L, Zhu H, Han B, Wang L, et al
    Influence of genetic polymorphisms of IL23R, STAT3, IL12B, and STAT4 on the risk of aplastic anemia and the effect of immunosuppressive therapy.
    Ann Hematol. 2018 Jan 12. pii: 10.1007/s00277-018-3227.
    PubMed     Text format     Abstract available

    December 2017
  33. VAN ZEVENTER IA, Schreurs JWGM, van den Berg E, Mulder AB, et al
    Efficacy of antithymocyte globulin as first-line treatment for aplastic anemia-a single-center experience.
    Ann Hematol. 2017 Dec 16. pii: 10.1007/s00277-017-3201.
    PubMed     Text format    

    November 2017
  34. SMART LR, Ambrose EE, Raphael KC, Hokororo A, et al
    Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Ann Hematol. 2017 Nov 16. doi: 10.1007/s00277-017-3182.
    PubMed     Text format     Abstract available

  35. VISWESHWAR N, Jaglal M, Sokol L, Zuckerman K, et al
    Chemotherapy-related anemia.
    Ann Hematol. 2017 Nov 4. doi: 10.1007/s00277-017-3155.
    PubMed     Text format    

  36. FERRAO J, Silva M, Goncalves L, Gomes S, et al
    Widening the spectrum of deletions and molecular mechanisms underlying alpha-thalassemia.
    Ann Hematol. 2017;96:1921-1929.
    PubMed     Text format     Abstract available

  37. KLONIZAKIS P, Klaassen R, Sousos N, Liakos A, et al
    Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.
    Ann Hematol. 2017;96:1937-1944.
    PubMed     Text format     Abstract available

  38. MAIRA D, Cassinerio E, Marcon A, Mancarella M, et al
    Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Ann Hematol. 2017;96:1931-1936.
    PubMed     Text format     Abstract available

    October 2017
  39. HOUSTON BL, Jayakar J, Wells RA, Lenis M, et al
    A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
    Ann Hematol. 2017 Oct 3. doi: 10.1007/s00277-017-3137.
    PubMed     Text format     Abstract available

  40. VILLEGAS A, Nunez R, Gaya A, Cuevas-Ruiz MV, et al
    Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.
    Ann Hematol. 2017;96:1727-1733.
    PubMed     Text format     Abstract available

    September 2017
  41. YANG N, Chen J, Zhang H, Dai Z, et al
    Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naive aplastic anemia: a systematic review and meta-analysis.
    Ann Hematol. 2017 Sep 30. doi: 10.1007/s00277-017-3136.
    PubMed     Text format     Abstract available

  42. KEDAR P, Parmar V, Devendra R, Gupta V, et al
    Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations.
    Ann Hematol. 2017 Sep 7. doi: 10.1007/s00277-017-3116.
    PubMed     Text format    

  43. GRAZIADEI G, Casoni FM, Annoni F, Cortinovis I, et al
    Transcranial color Doppler in stroke-free adult patients with sickle cell disease.
    Ann Hematol. 2017;96:1547-1555.
    PubMed     Text format     Abstract available

  44. RICCHI P, Meloni A, Costantini S, Spasiano A, et al
    Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
    Ann Hematol. 2017;96:1541-1546.
    PubMed     Text format     Abstract available

  45. RODEGHIERO F, Carli G
    Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
    Ann Hematol. 2017;96:1421-1434.
    PubMed     Text format     Abstract available

    August 2017
  46. FUJIWARA T, Fukuhara N, Ichikawa S, Kobayashi M, et al
    A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review.
    Ann Hematol. 2017 Aug 24. doi: 10.1007/s00277-017-3106.
    PubMed     Text format    

  47. ATTA EH, Lima CBL, Dias DSP, Cle DV, et al
    Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Ann Hematol. 2017 Aug 16. doi: 10.1007/s00277-017-3086.
    PubMed     Text format     Abstract available

  48. LI Q, Luo C, Luo C, Wang J, et al
    Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
    Ann Hematol. 2017;96:1389-1397.
    PubMed     Text format     Abstract available

  49. WIEBKING V, Hutker S, Schmid I, Immler S, et al
    Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Ann Hematol. 2017;96:1373-1377.
    PubMed     Text format     Abstract available

    July 2017
  50. KLAIHMON P, Vimonpatranon S, Noulsri E, Lertthammakiat S, et al
    Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with beta-thalassemia following bone marrow transplantation.
    Ann Hematol. 2017 Jul 26. doi: 10.1007/s00277-017-3070.
    PubMed     Text format     Abstract available

  51. ANTUNES FD, Propheta VGS, Vasconcelos HA, Cipolotti R, et al
    Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
    Ann Hematol. 2017;96:1121-1125.
    PubMed     Text format     Abstract available

    June 2017
  52. DE LACERDA MP, Guedes NR, Yamakawa PE, Pereira AD, et al
    Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with (del17p).
    Ann Hematol. 2017 Jun 9. doi: 10.1007/s00277-017-3039.
    PubMed     Text format    

  53. OKA S, Ono K, Nohgawa M
    Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation.
    Ann Hematol. 2017 Jun 2. doi: 10.1007/s00277-017-3032.
    PubMed     Text format    

  54. TESSOULIN B, Thomare P, Delande E, Moynard J, et al
    Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
    Ann Hematol. 2017;96:943-950.
    PubMed     Text format     Abstract available

  55. SURAPOLCHAI P, Chuansumrit A, Sirachainan N, Kadegasem P, et al
    A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease.
    Ann Hematol. 2017;96:1005-1014.
    PubMed     Text format     Abstract available

  56. BALDINI M, Marcon A, Ulivieri FM, Seghezzi S, et al
    Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables.
    Ann Hematol. 2017;96:995-1003.
    PubMed     Text format     Abstract available

  57. CASSINERIO E, Baldini IM, Alameddine RS, Marcon A, et al
    Pregnancy in patients with thalassemia major: a cohort study and conclusions for an adequate care management approach.
    Ann Hematol. 2017;96:1015-1021.
    PubMed     Text format     Abstract available

    May 2017
  58. CASTELLI R, Sciara S, Lambertenghi Deliliers G, Pantaleo G, et al
    Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study.
    Ann Hematol. 2017;96:779-786.
    PubMed     Text format     Abstract available

  59. LAI YK, Lai NM, Lee SW
    Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis.
    Ann Hematol. 2017;96:839-845.
    PubMed     Text format     Abstract available

    April 2017
  60. YOUSSRY I, Soliman N, Ghamrawy M, Samy RM, et al
    Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.
    Ann Hematol. 2017;96:597-603.
    PubMed     Text format     Abstract available

  61. ALASHKAR F, Vance C, Herich-Terhurne D, Preising N, et al
    Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.
    Ann Hematol. 2017;96:589-596.
    PubMed     Text format     Abstract available

  62. CHEN M, Zhuang J, Zhou D, Xu Y, et al
    Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
    Ann Hematol. 2017;96:581-587.
    PubMed     Text format     Abstract available

    March 2017
  63. GREGORY GP, Farrell A, Brown S
    Cold agglutinin disease complicated by acrocyanosis and necrosis.
    Ann Hematol. 2017;96:509-510.
    PubMed     Text format    

    February 2017
  64. PUIGVI L, Baumann T, Fernandez S, Castro P, et al
    Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia.
    Ann Hematol. 2017 Feb 21. doi: 10.1007/s00277-017-2957.
    PubMed     Text format    

  65. KNUPPEL E, Medinger M, Stehle G, Infanti L, et al
    Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.
    Ann Hematol. 2017 Feb 3. doi: 10.1007/s00277-017-2936.
    PubMed     Text format    

  66. KLAIHMON P, Phongpao K, Kheansaard W, Noulsri E, et al
    Microparticles from splenectomized beta-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
    Ann Hematol. 2017;96:189-198.
    PubMed     Text format     Abstract available

  67. WANG HC, Hsieh LL, Liu YC, Hsiao HH, et al
    The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
    Ann Hematol. 2017;96:183-188.
    PubMed     Text format     Abstract available

  68. BURKHARDT L, Lobitz S, Koustenis E, Rueckriegel SM, et al
    Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.
    Ann Hematol. 2017;96:199-213.
    PubMed     Text format     Abstract available

    January 2017
  69. OUEDERNI M, Ben Khaled M, Mellouli F, Ben Fraj E, et al
    Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
    Ann Hematol. 2017;96:133-139.
    PubMed     Text format     Abstract available

  70. BOGUSLAWSKA DM, Heger E, Machnicka B, Skulski M, et al
    A new frameshift mutation of the beta-spectrin gene associated with hereditary spherocytosis.
    Ann Hematol. 2017;96:163-165.
    PubMed     Text format    

  71. AL NAJJAR S, Adam S, Ahmed N, Qari M, et al
    Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Ann Hematol. 2017;96:141-146.
    PubMed     Text format     Abstract available

    December 2016
  72. LIANG XH, Rong L, He G, He H, et al
    Polymorphisms of the TGF-beta1 gene and the risk of acquired aplastic anemia in a Chinese population.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available

  73. OH DH, Motorna O, Kong JB, Brown S, et al
    Linezolid-associated reticulocytopenia.
    Ann Hematol. 2016;95:2095-2097.
    PubMed     Text format    

    November 2016
  74. GROTH M, Singer S, Niedeggen C, Petermann-Meyer A, et al
    Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available

    October 2016
  75. ZHANG XH, Wang QM, Chen H, Chen YH, et al
    Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation.
    Ann Hematol. 2016;95:1637-43.
    PubMed     Text format     Abstract available

  76. CRISP RL, Maltaneri RE, Vittori DC, Solari L, et al
    Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.
    Ann Hematol. 2016;95:1595-601.
    PubMed     Text format     Abstract available

  77. PHONDEECHAREON T, Wattanapanitch M, U-Pratya Y, Damkham C, et al
    Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
    Ann Hematol. 2016;95:1617-25.
    PubMed     Text format     Abstract available

  78. URESHINO H, Miyahara M
    Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer.
    Ann Hematol. 2016;95:1743-4.
    PubMed     Text format    

  79. HUANG Y, Wang M, Yu C, Lei Y, et al
    Clinical presentation of the hemoglobin Youngstown variant in a Chinese family.
    Ann Hematol. 2016;95:1925-7.
    PubMed     Text format    

  80. BALAIAN E, Schuster C, Schonefeldt C, Germing U, et al
    Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.
    Ann Hematol. 2016;95:1805-10.
    PubMed     Text format     Abstract available

    September 2016
  81. VAGACE JM, Cardesa R, Corbacho A, Vazquez T, et al
    Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.
    Ann Hematol. 2016;95:1419-27.
    PubMed     Text format     Abstract available

  82. LANZA F, Lazzari MC, Brambilla P, Di Martino G, et al
    An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man.
    Ann Hematol. 2016;95:1555-7.
    PubMed     Text format    

  83. HAGIWARA K, Kamesaki T, Kakimoto T, Fukushima K, et al
    Long-term follow-up of non-syphilitic paroxysmal cold hemoglobinuria in an adult.
    Ann Hematol. 2016;95:1547-9.
    PubMed     Text format    

    August 2016
  84. ZAREI T, Haghpanah S, Parand S, Moravej H, et al
    Evaluation of bone mineral density in patients with hemoglobin H disease.
    Ann Hematol. 2016;95:1329-32.
    PubMed     Text format     Abstract available

  85. KARIMI M, Haghpanah S, Pishdad P, Rachmilewitz EA, et al
    Frequency of silent cerebral ischemia in patients with transfusion-dependent beta-thalassemia major compared to healthy individuals.
    Ann Hematol. 2016;95:1387.
    PubMed     Text format    

  86. ZAFARI M, Kosaryan M, Gill P, Alipour A, et al
    Non-invasive prenatal diagnosis of beta-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis.
    Ann Hematol. 2016;95:1341-50.
    PubMed     Text format     Abstract available

    June 2016
  87. UPADHYE D, Jain D, Trivedi Y, Nadkarni A, et al
    Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients.
    Ann Hematol. 2016;95:1201-3.
    PubMed     Text format    

    May 2016
  88. MUSA BM, Galadanci NA, Coker M, Bussell S, et al
    The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available

  89. KARACAOGLU PK, Asma S, Korur A, Solmaz S, et al
    East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients.
    Ann Hematol. 2016;95:993-1000.
    PubMed     Text format     Abstract available

  90. CARLI G, Visco C, Falisi E, Perbellini O, et al
    Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
    Ann Hematol. 2016;95:863-70.
    PubMed     Text format     Abstract available

  91. PIERINI A, Mancusi A, Terenzi A, Massei MS, et al
    New mechanism of lymphoma-induced bone marrow aplasia.
    Ann Hematol. 2016;95:1013-5.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.